Journal of Investigative Dermatology

FIGURE 5

FROM:

Molecular Evaluation of Vitamin D3 Receptor Agonists Designed for Topical Treatment of Skin Diseases

Yvonne Bury, Dagmar Ruf, Christina Mørk Hansen, Anne-Marie Kissmeyer, Lise Binderup and Carsten Carlberg

BACK TO ARTICLE

Figure 5.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Agonistic effects of 1alpha,25(OH)2D3 and its analogs in vivo. Luciferase reporter gene assays were performed with extracts from HeLa cells that were transiently transfected with a reporter gene construct-driven by three copies of the GAL4 binding site and an expression vector for a GAL4DBDVDRLBD fusion protein (as schematically depicted above). The cells were treated for 16 h with graded concentrations of 1alpha,25(OH)2D3 or its analogs. Stimulation of luciferase activity was calculated in comparison with solvent-induced controls. Data points represent the mean of triplicates and the bars indicate SD. The EC50 values for stimulation of VDR-driven gene activity were determined from the respective dose–response curves.

BACK TO ARTICLE